These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21573198)

  • 1. Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors.
    Sottoriva A; Vermeulen L; Tavaré S
    PLoS Comput Biol; 2011 May; 7(5):e1001132. PubMed ID: 21573198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity.
    Sottoriva A; Verhoeff JJ; Borovski T; McWeeney SK; Naumov L; Medema JP; Sloot PM; Vermeulen L
    Cancer Res; 2010 Jan; 70(1):46-56. PubMed ID: 20048071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and phenotypic selection of cancer stem cells.
    Poleszczuk J; Hahnfeldt P; Enderling H
    PLoS Comput Biol; 2015 Mar; 11(3):e1004025. PubMed ID: 25742563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring cancer stem cell niche directed tumor growth.
    Sottoriva A; Sloot PM; Medema JP; Vermeulen L
    Cell Cycle; 2010 Apr; 9(8):1472-9. PubMed ID: 20372084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell plasticity and heterogeneity in cancer.
    Marjanovic ND; Weinberg RA; Chaffer CL
    Clin Chem; 2013 Jan; 59(1):168-79. PubMed ID: 23220226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic regulation of cancer stem cells and clinical challenges.
    Ni C; Huang J
    Clin Transl Oncol; 2013 Apr; 15(4):253-8. PubMed ID: 22926945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells: understanding tumor hierarchy and heterogeneity.
    Rich JN
    Medicine (Baltimore); 2016 Sep; 95(1 Suppl 1):S2-S7. PubMed ID: 27611934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts.
    Wang W; Quan Y; Fu Q; Liu Y; Liang Y; Wu J; Yang G; Luo C; Ouyang Q; Wang Y
    PLoS One; 2014; 9(1):e84654. PubMed ID: 24416258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.
    Yasuda H; Soejima K; Watanabe H; Kawada I; Nakachi I; Yoda S; Nakayama S; Satomi R; Ikemura S; Terai H; Sato T; Suzuki S; Matsuzaki Y; Naoki K; Ishizaka A
    Int J Oncol; 2010 Dec; 37(6):1537-46. PubMed ID: 21042723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crossroads between cancer stem cells and aging.
    Santos Franco S; Raveh-Amit H; Kobolák J; Alqahtani MH; Mobasheri A; Dinnyes A
    BMC Cancer; 2015; 15 Suppl 1(Suppl 1):S1. PubMed ID: 25708542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations.
    Gatenby RA; Cunningham JJ; Brown JS
    Nat Commun; 2014 Nov; 5():5499. PubMed ID: 25407411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenetics in cancer stem cells].
    Xu LF; Zhang J; Tian ZQ; Wu YZ
    Yi Chuan; 2013 Sep; 35(9):1049-57. PubMed ID: 24400477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for cancer stem cell elimination: insights from mathematical modeling.
    Vainstein V; Kirnasovsky OU; Kogan Y; Agur Z
    J Theor Biol; 2012 Apr; 298():32-41. PubMed ID: 22210402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastic Tunneling of Two Mutations in a Population of Cancer Cells.
    Haeno H; Maruvka YE; Iwasa Y; Michor F
    PLoS One; 2013; 8(6):e65724. PubMed ID: 23840359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary dynamics of tumor progression with random fitness values.
    Durrett R; Foo J; Leder K; Mayberry J; Michor F
    Theor Popul Biol; 2010 Aug; 78(1):54-66. PubMed ID: 20488197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.